APA (7th ed.) Citation

N, R., LA, G., & KK, B. (2026). Factors Associated with Omission of Axillary Lymph Node Dissection for Patients with Clinical Node-Positive Breast Cancer Who have Residual Nodal Disease on Pathology After Neoadjuvant Chemotherapy. Annals of surgical oncology. https://doi.org/10.1245/s10434-026-19968-5

Chicago Style (17th ed.) Citation

N, Rademacher, Gutnik LA, and Broman KK. "Factors Associated with Omission of Axillary Lymph Node Dissection for Patients with Clinical Node-Positive Breast Cancer Who Have Residual Nodal Disease on Pathology After Neoadjuvant Chemotherapy." Annals of Surgical Oncology 2026. https://doi.org/10.1245/s10434-026-19968-5.

MLA (9th ed.) Citation

N, Rademacher, et al. "Factors Associated with Omission of Axillary Lymph Node Dissection for Patients with Clinical Node-Positive Breast Cancer Who Have Residual Nodal Disease on Pathology After Neoadjuvant Chemotherapy." Annals of Surgical Oncology, 2026, https://doi.org/10.1245/s10434-026-19968-5.